SomaLogic enters into proteomics agreement with Beckman Coulter

Published: 23-Jul-2003

SomaLogic, a US proteomics company based in Boulder, Colorado, has entered into the first phase of a development agreement with Beckman Coulter, a leading manufacturer of medical laboratory instrument systems, chemistries and supplies.


SomaLogic, a US proteomics company based in Boulder, Colorado, has entered into the first phase of a development agreement with Beckman Coulter, a leading manufacturer of medical laboratory instrument systems, chemistries and supplies.

Under the agreement, SomaLogic will undertake a feasibility study aimed at integrating its aptamer protein capture agent technology with Beckman Coulter's Biomek liquid handling workstation and proprietary microarray-plate and array reader platforms. The project will be undertaken in conjunction with Beckman Coulter's Advanced Technology Center, which assesses the risks and benefits of new technologies for possible future product offerings.

'We are pleased to be working together to develop new approaches for array-based quantitative proteomics,' said Keith Warner, SomaLogic's chief business officer. "We look forward to the possibility of creating next-generation products that combine our aptamers with Beckman Coulter's industry-leading fluid handling systems and innovative array technologies.'

See more

You may also like

Analysis

Beckman introduces novel CE-Marked Hepatitis Assays at ESCMID Global

Read more
The HBsAg high positive algorithm eliminates the need for repeat and confirmatory testing for samples ≥ 100.00 S/CO

Trending Articles

  1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
  2. Abselion launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
  3. diaago and Peak Analysis & Automation partner to bring practical automation solutions to research laboratories Using diaago's customer-first approach with PAA’s decades of expertise in laboratory robotics, the collaboration promises to deliver solutions to streamline workflows, boost throughput and reduce bottlenecks
  4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
  5. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Analysis

Beckman introduces novel CE-Marked Hepatitis Assays at ESCMID Global

The HBsAg high positive algorithm eliminates the need for repeat and confirmatory testing for samples ≥ 100.00 S/CO
Manufacturing

Beckman Coulter unveils next-gen immunoassay analyser

“The DxI 9000 Access Immunoassay Analyser sets new expectations for immunoassay testing operational performance and ability to develop and sustain improved assay sensitivity"
Analysis

For improved customer service, the future is virtual

Responding to the unprecedented effects of the COVID-19 pandemic, Paul Paterson (PP), European Technical Director, Beckman Coulter Life Sciences (BCLS), chats to Dr Kevin Robinson (KSR) about how the company has embraced virtual reality (VR) technology and other remote diagnostic tools to ensure high levels of customer service both during and after the lockdowns
Analysis

Beckman Coulter partners with Smart4Diagnostics to close the data gap between blood collection and lab analysis

Beckman Coulter, a global clinical diagnostics leader, announces a new partnership with Germany-based company Smart4Diagnostics to close the preanalytical data gap between blood collection and laboratory analysis due to errors that take place before the sample arrives in the laboratory, such as sample collection, patient identification, sample handling, sample transportation, sample loss, etc.
Manufacturing

Beckman Coulter launches tabletop analyser for small labs

It’s designed to complement the company’s haematology analysers, including the DxH 690T for mid-volume and DxH 900 for high-volume
Analysis

Beckman Coulter launches COVID-19 antibody test

The company has launched in countries accepting CE Mark and will begin shipping to European diagnostics labs
Infection Control

Beckman Coulter launches its SARS-CoV-2 IgM antibody test

The test offers high accuracy crucial to reliably determine if a person has been exposed to the virus and if the patient has developed antibodies
Subscribe now